Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 11Gastrointestinal 10NET 7Sarcoma 4Thoracic 3CNS 3Head & Neck 2Genitourinary 2Dermatologic 2Breast 2Other solid neoplasm 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Prostatic Neoplasms 1310Carcinoma, Renal Cell 661Urinary Bladder Neoplasms 405Carcinoma, Non-Small-Cell Lung 334Neoplasms 301Carcinoma, Transitional Cell 264Breast Neoplasms 252Ovarian Neoplasms 248Melanoma 235Colorectal Neoplasms 228Neoplasm Metastasis 214Kidney Neoplasms 200Pancreatic Neoplasms 169Stomach Neoplasms 162Squamous Cell Carcinoma of Head and Neck 143Lung Neoplasms 140Uterine Cervical Neoplasms 123Non-Muscle Invasive Bladder Neoplasms 118Triple Negative Breast Neoplasms 112Head and Neck Neoplasms 111Endometrial Neoplasms 109Esophageal Neoplasms 107Carcinoma, Hepatocellular 98Small Cell Lung Carcinoma 80Sarcoma 75Colonic Neoplasms 55Urologic Neoplasms 53Prostatic Neoplasms, Castration-Resistant 47Liver Neoplasms 47Cholangiocarcinoma 43

Interventions

Sunitinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Adenoma, Islet Cell × Genitourinary × Clear all
NCT05800106 2023-04-10

A Bioequivalence Study of Sunitinib Malate Capsules.

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Completed
24 enrolled
GastrointestinalGenitourinarySarcoma

Carcinoma, Renal Cell, Adenoma, Islet Cell, Gastrointestinal Stromal Tumors

NCT00428220 2019-06-27

A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.

Pfizer

Phase NA Completed
223 enrolled 8 charts
BreastGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Adenoma, Islet Cell, Somatostatinoma, Thyroid Neoplasms, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡